Patients' medical attendance, hospitalization and laboratory requirements of the studied population (n = 204).

<p>^aNumber of patients' admissions to hospitals to counteract relapses within the last year. In this category, the visits to one-day clinics are not included.</p><p>^bThis information was missing in 7 patients.</p><p>^cThis information was missing in 2 patients.</p><p>Patients' medical attendance, hospitalization and laboratory requirements of the studied population (n = 204).</p

Demographic and clinical attendance characteristics of the studied population (n = 204).

<p>^aDuration since diagnosis of CIS or clinically definite MS until study enrollment.</p><p>^bIKA: Social Insurance Institute, OPAD: Insurance institute for employees of the public sector, ΟAEE: Insurance institute for freelancers. One patient had both “other public insurance” and “private insurance”.</p><p>Demographic and clinical attendance characteristics of the studied population (n = 204).</p

Health care service use related to visits to neurologists, other doctors and health professionals.

<p>Health care service use related to visits to neurologists, other doctors and health professionals.</p

Patient evaluation of the received information and help/support on multiple sclerosis.

<p>^aAny patient with missing values was excluded from analysis due to lack of information retrieval by the corresponding source.</p><p>^bAbsence of answer in the relevant field of the CRF was considered as no participation in patient union. In total, 86.27% of the study population reported participation in MS unions.</p><p>^cAbsence of answer in the relevant field of the CRF was considered as no participation in patient support program. In total, 74.02% of the study population reported participation in support programs.</p><p>Patient evaluation of the received information and help/support on multiple sclerosis.</p